​

Funding Round

Venture Round - BOYDSenseBOYDSense SAS

Venture Round - BOYDSenseBOYDSense SAS

Investment Firm

Overview

BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath.

Announced Date

Apr 05, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund is a early_stage_venture and venture firm.

Participant Investors

6

Investor Name
Participant InvestorSweet Ventures
Participant InvestorAlpha MOS
Participant InvestorJolt Capital
Participant InvestorBioSerenity
Participant InvestorEuropean Innovation Council

Round Details and Background

BOYDSenseBOYDSense SAS raised $7590544 on 2024-04-05 in Venture Round

BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 06, 2022
Grant - BOYDSenseBOYDSense SAS
1-2.8M
Apr 05, 2024
Venture Round - BOYDSenseBOYDSense SAS
7-7.6M

Recent Activity

There is no recent news or activity for this profile.